Abstract
Many activities are now ascribed to the monokine interleukin 11 including enhancement of immune responses, stimulation of thymocyte proliferation2, activation of B cells3, stimulation of proteinase and prostaglandin production by connective tissue cells4, stimulation of the production of acute phase proteins5, induction of fever6 and the induction of neutrophilia7. These activities were thought to be due to various different factors, but are now considered probably due to very similar, if not identical, molecules8–11. The term interleukin 1 (IL-1) was coined to describe the factor released by monocyte/macrophages which acts on T and B lymphocytes. Only after this definition had been accepted was it shown that target cells other than lymphocytes were affected by IL-1. Products of human blood monocytes (mononuclear cell factor, MCF) have been implicated in the pathogenesis of inflammatory diseases such as rheumatoid arthritis and periodontal disease12,13. Bone resorption is often a feature of such diseases, and monocytes are frequently found at sites of localized bone resorption. Preliminary experiments with monocyte-conditioned medium indicated that MCF could stimulate bone resorption14. We therefore undertook this study to verify these observations and to determine whether purified IL-1 could stimulate connective tissue breakdown in vitro.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Oppenheim, J. J. & Gery, I. Immun. Today. 3, 113–119 (1982).
Gery, I., Gershon, R. K. & Waksman, B. H. J. exp. Med. 136, 128–142 (1972).
Wood, D. D. & Gaul, S. L. J. Immun. 113, 925–933 (1974).
Dayer, J. M., Stephenson, M. L., Schmidt, E., Karge, W. & Krane, S. M. FEBS Lett. 124, 253–256(1981).
Wannenmacher, R. W. et al. Endocrinology 96, 651–661 (1975).
Dinarello, C. A., Goldin, N. P. & Wolff, S. M. J. exp. Med. 139, 1396–1381 (1974).
Merriman, C. R., Pulliam, L. A. & Kampschmidt, R. A. Proc. Soc. exp. Biol. Med. 154, 224–227 (1977).
Wood, D. D. J. Immun. 123, 2400–2407 (1979).
Mizel, S. B., Dayer, J. M., Krane, S. M. & Mergenhagen, S. E. Proc. natn. Acad. Sci. U.S.A. 78, 2474–2477 (1981).
Sztein, M. B. et al. Cell. Immun. 63, 164–176 (1981).
Murphy, P. A., Simon, P. L. & Willoughby, W. F. J. Immun. 124, 2498–2501 (1980).
Krane, S. M. Annls. rheum Dis. 40, 433–448 (1981).
Russell, R. G. G., McGuire, M. K. B., Meats, J. E., Ebsworth, N. M. & Beresford, J. Scand. J. Rheum. Suppl. 40, 75–87 (1981).
Gowen, M., Meikle, M. C. & Reynolds, J. J. Biochim. biophys. Acta. 762, 471–474 (1983).
Wood, D. D. & Cameron, P. M. Cell Immun. 21 133–145(1976).
Wood, D. D. J. Immun. 123, 2395–2399 (1979).
Meikle, M. C., Gowen, M. & Reynolds, J. J. Calcified Tissue Int. 34, 359–364 (1982).
Aarden, L. A. et al. J. Immun. 123, 2928–2929 (1979).
Mizel, S. B. Molec. Immun. 17, 571–577 (1980).
Dinarello, C. A., Bendtzen, K. & Wolff, S. M. Inflammation 6, 63–78 (1982).
Horton, J. E. et al. Science 177, 793–795 (1972).
Mundy, G. R., Raisz, L. G., Cooper, R. A., Schechter, G. P. & Salmon, S. E. New Engl. J. Med. 291, 1041–1046 (1974).
Luben, R. A. Biochem. biophys. Res. Commun. 84, 15–22 (1978).
Mundy, G. R., Luben, R. A., Raisz, L. G., Oppenheim, J. J. & Buell, D. N. New Engl. J. Med. 290, 867–871 (1974).
Yoneda, T. & Mundy, G. R. J. exp. Med. 150, 338–350 (1979).
Bockman, R. S. & Repo, M. J. exp. Med. 154, 529–539 (1981).
McGuire, M. K. B. et al. Int. J. Immunopharmac. 4, 91–102 (1982).
Wood, D. D., Ihrie, E. J., Dinarello, C. A. & Cohen, P. L. Arthr. Rheum. 26, 975–983 (1983).
Reynolds, J. J. in Organ Culture in Biomedical Research (eds Balls, M. & Monnickendam, M.) 355–366 (Cambridge University Press, 1976).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gowen, M., Wood, D., Ihrie, E. et al. An interleukin 1 like factor stimulates bone resorption in vitro. Nature 306, 378–380 (1983). https://doi.org/10.1038/306378a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/306378a0
This article is cited by
-
SARS-CoV-2 infection induces inflammatory bone loss in golden Syrian hamsters
Nature Communications (2022)
-
Circulating Extracellular Vesicles Express Receptor Activator of Nuclear Factor κB Ligand and Other Molecules Informative of the Bone Metabolic Status of Mouse Models of Experimentally Induced Osteoporosis
Calcified Tissue International (2022)
-
Pathophysiological mechanisms of root resorption after dental trauma: a systematic scoping review
BMC Oral Health (2021)
-
Circulating Levels of Inflammation and the Effect on Exercise-Related Changes in Bone Mass, Structure and Strength in Middle-Aged and Older Men
Calcified Tissue International (2019)
-
A review of biomarkers in peri-miniscrew implant crevicular fluid (PMICF)
Progress in Orthodontics (2017)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.